Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Sponsor
Full profile: /officials/D000563
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512)
2026-02-05
Source: Congress.gov
Plain-English Summary
This bill would ban the sale and distribution of tianeptine, a drug sometimes sold as a dietary supplement or nootropic that can cause addiction and serious health problems, along with other potentially dangerous products. The ban would apply to retailers, online sellers, and manufacturers who currently market these substances to consumers. The legislation aims to protect public health by preventing access to drugs that lack proper FDA approval and oversight.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- SRES815A resolution commending the Chicago Cubs baseball teams as it celebrates its 150th anniversary on August 29, 2026.Referred to Committee · 2026-08-07
- S3444A bill to designate the facility of the United States Postal Service at 1300 East Northwest Highway in Palatine, Illinois, as the "Bernie Bluestein Post Office Building".Referred to Committee · 2026-08-06
- S5194Judicial Space and Facilities Management Effectiveness Act of 2026Referred to Committee · 2026-07-30
- S1516Cahokia Mounds Mississippian Culture Study ActReported by Committee · 2026-07-23